Speaker: Ari Hakimian, DO , Hematology/Oncology Fellow, Advocate Lutheran General Hospital

Journal Articles:

  1. CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease | NEJM

       2. Phase 3 Trial of Concizumab in Hemophilia with Inhibitors | NEJM

Session date: 
11/16/2023 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit

Please login or register to take this course.